|Articles|April 4, 2020

Authors in The American Journal of Managed Care® Call for Embracing Telemedicine Amid “Uncontained Spread” of COVID-19

Two members of the law firm Jones Day say even healthcare providers who have not used telemedicine should plan for it as the novel coronavirus spreads, now that rapidly changing laws erase the red tape that has limited use.

CRANBURY, N.J.--(BUSINESS WIRE)--Writers in the April issue of The American Journal of Managed Care^® call on healthcare providers to embrace telemedicine to address the “unique challenges” of the COVID-19 outbreak, which they say can prevent overcrowding in emergency departments and clinics and help contain disease spread.

“Incorporating Telemedicine as Part of COVID-19 Outbreak Response Systems,” from Jones Day attorneys Kimberly Lovett Rockwell, MD, JD, and Alexis S. Gilroy, JD, outlines how state, federal and international telemedicine laws are evolving to accommodate telemedicine—both to allow public payers such as Medicare to cover it and to allow nonphysician providers to be compensated.

“Because of this mounting public urgency and currently uncontained spread, healthcare providers are already experiencing and must prepare for additional increased volumes of both sick and worried-well patients that could strain hospital care units and medical equipment supply chains,” the authors say.

Telemedicine, they write, is for everyone, from primary care to urgent care to specialty providers. “Even healthcare providers who have not yet adopted telemedicine capabilities should consider implementing narrowly designed systems to mitigate the expected increase in volumes of low-acuity patients seeking reassurance.”

For the full article, published online ahead of print click, click here.

About The American Journal of Managed Care®

The American Journal of Managed Care® (AJMC®) is a multimedia peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision-makers. Other brands in the AJMC® family include The American Journal of Accountable Care®, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive multimedia brands bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. AJMC® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

Contact

AJMC® Media Contact

Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhlifesciences.com

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Authors in The American Journal of Managed Care® Call for Embracing Telemedicine Amid “Uncontained Spread” of COVID-19

Newsletter

Related Content

Recon Strategy: More Frequent Visits to Primary Care Can Save Net $30-40 PMPM for Top 20% Highest Risk Commercial Members

The American Journal of Managed Care® Announces a Call for Manuscript Submissions for the 15th Annual Health Information Technology Special Issue

The American Journal of Managed Care® Introduces Population Health, Equity & Outcomes – An Exciting Rebrand of The American Journal of Accountable Care®

The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award

The American Journal of Managed Care® Announces Call for Manuscript Submissions for the 14th Annual Health Information Technology Special Issue

Latest CME

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Overview and Burden of Migraine

The Role of the Pharmacist Migraine Management

The Evolving Treatment Landscape of Migraine

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

How Medicaid Reforms Could Deepen State Coverage Gaps

Survey Reveals Clinician Confidence Around Using AI in PA Process

FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC

Flow Cytometry Tool Could Improve Treatment Monitoring in MS